Cargando…
Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders
Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular sensor that detects small peptides derived from the cell wall component of intestinal microflora. NOD1 is expressed in both non-hematopoietic cells such as epithelial cells and hematopoietic cells such as antigen-presenting cells...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743859/ https://www.ncbi.nlm.nih.gov/pubmed/29021509 http://dx.doi.org/10.2183/pjab.93.037 |
_version_ | 1783288640428834816 |
---|---|
author | WATANABE, Tomohiro ASANO, Naoki KUDO, Masatoshi STROBER, Warren |
author_facet | WATANABE, Tomohiro ASANO, Naoki KUDO, Masatoshi STROBER, Warren |
author_sort | WATANABE, Tomohiro |
collection | PubMed |
description | Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular sensor that detects small peptides derived from the cell wall component of intestinal microflora. NOD1 is expressed in both non-hematopoietic cells such as epithelial cells and hematopoietic cells such as antigen-presenting cells. Detection of its ligand by NOD1 leads to innate immune responses through activation of nuclear factor kappa B and type I interferon as well as induction of autophagy. Innate immune responses through NOD1 activation play an indispensable role both in host defense against microbial infection and in the development of gastrointestinal disorders. Of particular importance, NOD1-mediated innate immune responses are associated with mucosal host defenses against Helicobacter pylori (H. pylori) infection of the stomach and with the development of pancreatitis. In this review, we discuss the molecular mechanisms by which NOD1 activation leads to the development of H. pylori-related gastric diseases and pancreatitis. |
format | Online Article Text |
id | pubmed-5743859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Japan Academy |
record_format | MEDLINE/PubMed |
spelling | pubmed-57438592018-01-04 Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders WATANABE, Tomohiro ASANO, Naoki KUDO, Masatoshi STROBER, Warren Proc Jpn Acad Ser B Phys Biol Sci Review Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular sensor that detects small peptides derived from the cell wall component of intestinal microflora. NOD1 is expressed in both non-hematopoietic cells such as epithelial cells and hematopoietic cells such as antigen-presenting cells. Detection of its ligand by NOD1 leads to innate immune responses through activation of nuclear factor kappa B and type I interferon as well as induction of autophagy. Innate immune responses through NOD1 activation play an indispensable role both in host defense against microbial infection and in the development of gastrointestinal disorders. Of particular importance, NOD1-mediated innate immune responses are associated with mucosal host defenses against Helicobacter pylori (H. pylori) infection of the stomach and with the development of pancreatitis. In this review, we discuss the molecular mechanisms by which NOD1 activation leads to the development of H. pylori-related gastric diseases and pancreatitis. The Japan Academy 2017-10-11 /pmc/articles/PMC5743859/ /pubmed/29021509 http://dx.doi.org/10.2183/pjab.93.037 Text en © 2017 The Japan Academy This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review WATANABE, Tomohiro ASANO, Naoki KUDO, Masatoshi STROBER, Warren Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
title | Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
title_full | Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
title_fullStr | Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
title_full_unstemmed | Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
title_short | Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
title_sort | nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743859/ https://www.ncbi.nlm.nih.gov/pubmed/29021509 http://dx.doi.org/10.2183/pjab.93.037 |
work_keys_str_mv | AT watanabetomohiro nucleotidebindingoligomerizationdomain1andgastrointestinaldisorders AT asanonaoki nucleotidebindingoligomerizationdomain1andgastrointestinaldisorders AT kudomasatoshi nucleotidebindingoligomerizationdomain1andgastrointestinaldisorders AT stroberwarren nucleotidebindingoligomerizationdomain1andgastrointestinaldisorders |